Pepsinogen Release and Acid Secretion from Human and Guinea Pig Gastric Mucosa Compromised by Hypoxia, Endotoxin, or Critical Illness

References

• Czaja A J, McAlhany J C, Pruitt B A, Jr. Acute gas-troduodenal disease after thermal injury: An endo-scopic evaluation of incidence and natural history. N Engl J Med 1974; 291: 925–929
   PubMed Web of Science ®Google Scholar
• Halloran L G, Zfass A M, Gayle W E, Wheeler C B, Miller J D. Prevention of acute gastrointestinal complications after severe head injury; A controlled trial of cimetidine prophylaxis. Am J Surg 1980; 139: 44–49
   PubMed Web of Science ®Google Scholar
• Peura D A, Johnson L R. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med 1985; 103: 173–177
   PubMed Web of Science ®Google Scholar
• Zinner M J, Zuidema G D, Smith P L, Mignosa M. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynec Obstet 1981; 153: 214–220
   PubMedGoogle Scholar
• Hastings P R, Skilllman J J, Bushness L S, Silen W S. Antacid prophylaxis of bleeding in the critically ill. N Engl J Med 1978; 298: 1041–1045
   PubMed Web of Science ®Google Scholar
• McGuigan J E. A consideration of the adverse effects of cimetidine. Gastroenterology 1981; 80: 181–192
   PubMed Web of Science ®Google Scholar
• Feretis C B, Contou C T, Papoutsis G G, et al. The effect of preoperative treatment with cimetidine on postoperative wound sepsis. Am Surg 1984; 50: 594–652
   PubMed Web of Science ®Google Scholar
• Axon A TR. Potential hazards of hypochlorhydria in the treatment of peptic ulcer. Scand J Gastroenterol 1986; 21(suppl 122)17–21
   Google Scholar
• Driks M K, Craven D E, Celli B R, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med 1987; 317: 1376–1382
   PubMed Web of Science ®Google Scholar
• Stremple J F, Molot M D, McNamara J, Mori H, Glass G BJ. Posttraumatic gastric bleeding: prospective gastric secretion composition. Arch Surg 1972; 105: 177–185
   PubMedGoogle Scholar
• O'Neill J A. The influence of thermal burns on gastric acid secretion. Surgery 1970; 67: 267–271
   PubMed Web of Science ®Google Scholar
• Pearson J P, Ward R, Allen A, Roberts N B, Taylor W H. Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration. Gut 1986; 27: 243–248
   PubMed Web of Science ®Google Scholar
• Venables C W. Mucus, pepsin, and peptic ulceration. Gut 1986; 27: 233–238
   PubMed Web of Science ®Google Scholar
• Rotter J I, Sones J Q, Samloff I M, et al. Duodenal ulcer disease associated with elevated serum pepsinogen I. N Engl J Med 1979; 300: 63–66
   PubMed Web of Science ®Google Scholar
• Samloff I M, Stemmermann G N, Heilbrun L K, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology 1986; 90: 570–576
   PubMed Web of Science ®Google Scholar
• Venabies C W. The secretion of pepsin 1 in peptic ulceration and its relationship to activity. Br J Surg 1971; 58: 864
   Web of Science ®Google Scholar
• Hirschowitz B I. Factors influencing pentagastrin dose response of acid, chloride and pepsin in peptic ulcer. Gut peptides and ulcer, A Miyoshi. Biomedical Research Foundation, Tokyo 1982; 357–365
   Google Scholar
• Schiffrin M J, Warren A A. Some factors concerned in the production of experimental ulceration of the gastrointestinal tract in cats. Am J Dig Dis 1942; 9: 205–209
   Google Scholar
• Kivilaakso E, Barzilai A, Schiessel R, Crass R, Silen W. Ulceration of isolated amphibian gastric mucosa. Gastroenterology 1979; 77: 31–37
   PubMed Web of Science ®Google Scholar
• Wallace J L, Whittle B JR. Role of mucus in the repair of gastric epithelial damage in the rat: inhibition of epithelial recovery by mucolytic agents. Gastroenterology 1986; 91: 603–611
   PubMed Web of Science ®Google Scholar
• Hirschowitz B I. The control of pepsinogen secretion. Ann NY Acad Sci 1967; 140: 709–723
   PubMed Web of Science ®Google Scholar
• Hersey S J, Miller M, May D, Norris S H. Lack of interaction between acid and pepsinogen secretion in isolated gastric glands. Am J Physiol 1983; 245: G775–G779
   Google Scholar
• Sandvik A K, Kleveland P M, Waldum H L. Stimulated pepsin secretion after omeprazole-induced acid suppression in the totally isolated vascularly perfused rat stomach. Scand J Gastroenterol 1987; 22: 362–366
   PubMed Web of Science ®Google Scholar
• Basson M D, Zucker K A, Adrian T E, Zdon M J, Ballantyne G H, Modlin I M. Pepsin release by prostaglandin El analogue: a potential therapeutic problem. Arch Surg 1988; 123: 432–434
   Google Scholar
• Basson M D, Adrian T E, Modlin I M. Dissociation of pepsinogen and acid secretion in the guinea pig. Gastroenterology 1988; 95: 321–326
   PubMed Web of Science ®Google Scholar
• Pearson J P, Ward R, Allen A, Roberts V B, Taylor W H. Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration. Gut 1986; 27: 243–248
   PubMed Web of Science ®Google Scholar
• Bihari D, Smithies M, Gimson A, Tinker J. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 1987; 317: 397–403
   PubMed Web of Science ®Google Scholar
• Levin J, Poore T E, Young N S, et al. Gram-negative sepsis: detection of endotoxemia with the Limulus test. Ann Intern Med 1972; 76: 1–7
   PubMed Web of Science ®Google Scholar
• Winchurch R A, Thupari J N, Munster A M. Endotoxemia in burn patients: levels of circulating endotoxins are related to burn size. Surgery 1987; 102: 808–812
   PubMed Web of Science ®Google Scholar
• Rutten M J, Ito S. Morphology and electrophy-siology of guinea pig gastric mucosal repair in vitro. Am J Physiol 1983; 244: G171–G182
   Google Scholar
• Finke U, Rutten M, Murphy R A, Silen W. Effects of epidermal growth factor on acid secretion from guinea pig gastric mucosa: in vitro analysis. Gastroenterology 1985; 88: 1175–1182
   PubMed Web of Science ®Google Scholar
• Kidder G W. Electrophysiology of the frog gastric mucosa with sufficient CO2. Am J Physiol 1975; 228: 928–933
   PubMedGoogle Scholar
• Sanders S S, Hayne V B, Rehm W S. Normal H+ rates in frog stomach in absence of exogenous CO2 and a note on pH stat method. Am. J Physiol 1973; 225: 1311–1321
   Google Scholar
• Sen P C, Tague L L, Ray T K. Secretion of H+ and K+ by bullfrog gastric mucosa: Characterization of K+ transport pathway. Am J Physiol 1980; 239: G484–G492
   Google Scholar
• Impicciatore M, Hansen D G, Rachmilewitz D, Maitra S K, Lugaro G, Grossman M I. Comparison of human urine gastric inhibitor (HUGI) and bacterial endotoxin as inhibitors of acid secretion. Eur J Pharmacol 1980; 65: 365–368
   PubMed Web of Science ®Google Scholar
• Payne J G, Bowen J C. Hypoxia of canine gastric mucosa caused by Escherichia coli sepsis and prevented with methylprednisolone therapy. Gastroenterology 1981; 80: 84–93
   PubMed Web of Science ®Google Scholar
• Menguy R, Masters Y F. Gastric mucosal energy metabolism and ‘stress ulceration’. Ann Surg 1974; 180: 538–548
   PubMed Web of Science ®Google Scholar
• Domschke W, Lux G, Domschke S. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine. Gastroenterology 1980; 79: 1267–1271
   PubMed Web of Science ®Google Scholar
• Hirschowitz B I, Danilewitz M, Molins E. Inhibition of basal acid, chloride and pepsin secretion in duodenal ulcer by graded doses of ranitidine and atropine with studies of pharmacokinetics of ranitidine. Gastroenterology 1982; 82: 1314–1326
   PubMed Web of Science ®Google Scholar
• Albillos A, Abreu L, Alvarez-Mon M, et al. Study of the secretion of pepsinogen I in cirrhotic humans with and without portocaval shunt. Am J Gastroenterol 1988; 83: 37–41
   PubMed Web of Science ®Google Scholar
• Idjadi F, Robbins R, Stahl W M, Essiet G. Prospective study of gastric secretion in stressed patients with intracranial injury. J Trauma 1971; 11: 681–688
   PubMedGoogle Scholar
• Walker P, Luther J, Samloff I M, Feldman M. Life events stress and psychosocial factors in men with peptic ulcer disease. II. Relations with serum pepsinogen concentrations and behavioral risk factors. Gastroenterology 1988; 94: 323–330
   PubMed Web of Science ®Google Scholar
• Walker V, Taylor W H. Pepsin 1 secretion in peptic ulcer and stress. Clin Sci Mol Med 1976; 51: 14
   Google Scholar
• Koelz J R, Hersey S J, Sachs G, Chew C S. Pepsonogen release from isolated gastric glands. Am J Physiol 1982; 243: G218–G225
   Google Scholar
• Matsumoto H, Dickinson K EJ, Shirakawa T, Komiyama K, Hirschowitz B I. Synergism between cellular messengers and agonist combinations in pepsinogen secretion. Am J Physiol 1987; 253: G557–G565
   Google Scholar
• Ballantyne G H, Zdon M J, Schafer D E, et al. Evidence for dual modulation of pepsinogen secretion using isoproterenol, carbachol, CCK-8, forskolin, 8 bromo-cAMP, and A23187 probes. Ann Surg 1986; 204: 559–565
   PubMed Web of Science ®Google Scholar
• Walker V, Taylor W H. Cigarette smoking, chronic peptic ulceration and peptic 1 secretion. Gut 1979; 20: 971–976
   PubMed Web of Science ®Google Scholar
• Wright C L, Shaw B, Sanders D J, Reed J D. Variations in the proportion of individual pepsins secreted by the cat in response to vagal stimulation and hypoglycemia. Clin Sci Mol Med 1975; 48: 297–305
   PubMedGoogle Scholar
• Ohe K, Yokoya H, Kitaura T. Increase in pepsin content during the course of aspirin- and tauro-cholate-induced gastrin ulceration in rats. Dig Dis Sci 1980; 25: 849–856
   PubMed Web of Science ®Google Scholar
• Zinner M J, Turtinen L, Gurll N J. Stress ulceration and the gastric mucosal barrier. Am Surg 1975; 41: 209–213
   PubMed Web of Science ®Google Scholar
• Schlamowitz M, Peterson L U. Studies on the optimum pH for the action of pepsin on ‘native’ and denatured bovine serum albumin and bovine hemoglobin. J Biol Chem 1950; 234: 3137–3145
   Google Scholar
• Brouwers J RBJ. Pathofysiologie en Farmacatherapie van peptische afwijkingen. Thesis, University of Amsterdam. 1981, As cited in: Wieriks J, Jaitly KD, Koekkoek PH, Lavy U. Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL®). Scand J Gastroenterol 1982, 17(suppl 80), 11–16.
   Google Scholar
• Wieriks J, Jaitly K D, Koekkoek P H, Lavy U. Pharmacological properties of colloidal bismuth sub-citrate (CBS, DE-NOL®). Scand J Gastroenterol 1982; 17(suppl 80)11–16
   PubMedGoogle Scholar
• Baron J H, Barr J, Batten J, Sidebotham R, Spencer J. Acid, pepsin and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol). Gut 1986; 27: 486–491
   PubMed Web of Science ®Google Scholar
• Samioff I M, O'Dell C. Inhibition of peptic activity by sucralfate. Am J Med 1985; 79(suppl 2C)15–18
   PubMed Web of Science ®Google Scholar